Columnist Jennifer Lynne interviews 75-year-old Chip Hailey about his life leading up to receiving gene therapy for hemophilia B.

VIJAYAWADA: The State government is committed to ensuring uninterrupted care for citizens with rare and chronic disorders ...

The approval in previously treated pediatric patients was based on data from the Alfa-PROTECT and PROTECT Kids studies.

Treatment options for children with hemophilia A have expanded with the FDA approval of Bayer's Jivi antihemophilic factor (recombinant), PEGylated-aucl for the treatment of pediatric patients between ...

Hemophilia is a rare disorder in which the blood does not clot properly. It affects around 1 in 10,000 people, mostly males ...

Results of a real-world study that included people with hemophilia from 33 countries show that people with hemophilia B, ...

Preventive treatment options that don't involve the use of FVIII or FIX are needed for patients who develop inhibitors, ...

In the1950s, patients like my father benefitted from scientific breakthroughs: Researchers identified the two types of ...

Discover how hemophilia A affects blood clotting, its genetic patterns, warning signs, advanced treatment options, and ...

Learn when uncontrolled bleeding becomes dangerous and requires immediate medical attention. Discover effective first aid ...

Nonhuman primate (NHP) study in hemophilia A demonstrated therapeutically relevant factor VIII (FVIII) activity with durable response through approximately 19 months with an encouraging safety profile ...

Joint supplements like glucosamine, chondroitin, and methylsulfonylmethane are used to prevent and treat arthritis pain. However, the science is unclear on what the best joint supplements are for ...